Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Research groups

Tonia Thomas

DPhil, BSc (Hons)

Vaccine Knowledge Project Manager

  • DPhil Physiology Anatomy & Genetics
  • Wilkinson Junior Research Fellow

After completing my BSc in Pharmacology at the University of Liverpool, I undertook my DPhil as part of the British Heart Foundation Oxbridge Centre of Regenerative Medicine. For my DPhil research I investigated the molecular mechanisms involved with forming new blood vessels after a heart attack, particularly focusing on the endocardium as a source of de novo coronary vessels. This project employed molecular biology techniques and genetic sequencing to uncover novel pathways for therapeutic potential.

During the course of my DPhil I maintained interests in public health, policy, and outreach, and alongside my research I engaged in voluntary work, conferences and societies to expand my knowledge in these areas. I have been involved with University outreach projects such as Oxford Hands-On Science, Pathways and Oxplore, aiming to widen access to higher education and engage children and young people in STEM. I have also worked remotely and locally on international projects such as supporting Ugandan social enterprise ventures with UniTED OxMAK, University of Makerere, Kampala, and chairing international debates for GlobalMUN, Shanghai. 

I joined the Oxford Vaccine Group in 2019 as the Vaccine Knowledge Project Manager. I maintain the Vaccine Knowledge Project website and lead the communications strategy for Vaccine Advocacy in the group. I also manage Patient and Public Involvement at OVG, including the development of the group's PPI Framework. I engage with schools, health professionals and the public to share knowledge on vaccine development and vaccine attitudes, and collaborate with clinical investigators and social science researchers to ensure we are using the most relevant evidence-based approaches for our work.